A World Health Organization (WHO) expert panel countered concerns over the efficacy of the AstraZeneca COVID vaccine on Wednesday, insisting that “it’s
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced findings from its first ever World COPD Day survey ahead of the awareness day on November 18.
MoreAnyone can have mild to severe symptoms.
Older adults and people who have severe underlying medical conditions like heart or lung disease or diabetes seem to be at higher risk for developing more serious complications from COVID-19 illness.
Influenza (Flu) and COVID-19 are both contagious respiratory illnesses, but they are caused by different viruses. COVID-19 is caused by infection with a new coronavirus (called SARS-CoV-2) and flu is caused by infection with influenza viruses.
MoreIf you are sick with COVID-19 or think you might have COVID-19, follow the steps below to care for yourself and to help protect other people in your home and community.
MoreTravel increases your chance of getting and spreading COVID-19. Staying home is the best way to protect yourself and others from COVID-19.
MoreThe Centers for Medicare & Medicaid Services announced that starting today, Medicare beneficiaries can receive coverage of monoclonal antibodies to treat coronavirus disease 2019 (COVID-19) with no cost-sharing during the public health emergency (PHE).
MoreThe ranking acknowledges Roche's commitment to sustainability as an integral part of its business strategy
More“Many efforts have been made to prevent and treat diabetes”, but the disease continues to rise rapidly in low and middle income countries, those “least well-equipped with the diagnostics, medicines, and knowledge to provide life-saving treatment”, said Secretary-General António Guterres.
MoreWHO today listed the nOPV2 vaccine (Bio Farma, Indonesia) for emergency use to address the rising cases of a vaccine-derived polio strain in a number of African and East Mediterranean countries.
MoreThe United States filed suit to halt the sale by a New Jersey entity of an unapproved “nano silver” product previously touted as a COVID-19 treatment, the Department of Justice announced today.
More